MedPage Today -- The antiarrhythmic drug dronedarone (Multaq), approved last year, is only modestly effective and not significantly safer than the drug it was designed to replace, researchers said.
MedPage Today -- The antiarrhythmic drug dronedarone (Multaq), approved last year, is only modestly effective and not significantly safer than the drug it was designed to replace, researchers said.
